Infectious Diseases (except HIV/AIDS)
Showing page 195 of 716 pages of list content
-
Drivers of adaptive evolution during chronic SARS-CoV-2 infections
This article's authors -
Factors associated with the decay of anti-SARS-CoV-2 neutralizing antibodies among recipients of an adenoviral vector-based AZD1222 and a whole-virion inactivated (BBV152) vaccine in Chennai, India: a prospective, longitudinal, cohort study
This article's authors -
Tracing the trajectories of SARS-CoV-2 variants of concern between December 2020 and September 2021 in the Canary Islands (Spain)
This article's authors -
Real-world Effectiveness of Casirivimab and Imdevimab in Patients With COVID-19 in the Ambulatory Setting: An Analysis of Two Large US National Claims Databases
This article's authors -
Study on the usefulness of Direct Saliva sample Collection (DiSC) by polyester swab
This article's authors -
Presence of Symptoms 6 Weeks After COVID-19 Among Vaccinated and Unvaccinated U.S. Healthcare Personnel
This article's authors -
CoviVac vaccination induces production of neutralizing antibodies against Delta and Omicron variants of SARS-CoV-2
This article's authors -
Effectiveness of the third dose of BNT162b2 vaccine on neutralizing Omicron variant in the Japanese population
This article's authors -
Quantifying antibody dynamics of severe and non-severe patients with COVID-19
This article's authors -
Third dose of COVID-19 vaccine, CVnCoV, increased neutralizing activity against SARS-CoV-2 wild-type and Delta variant
This article's authors